{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:21:50Z","timestamp":1790626910284,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:00:00Z","timestamp":1724544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:00:00Z","timestamp":1724544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330031"],"award-info":[{"award-number":["82330031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271896"],"award-info":[{"award-number":["82271896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32241018"],"award-info":[{"award-number":["32241018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key R&D Program"},{"name":"Postdoctoral Fellowship Program of CPSF"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51624-y","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T09:01:54Z","timestamp":1724576514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Multi-omics profiling of retinal pigment epithelium reveals enhancer-driven activation of RANK-NFATc1 signaling in traumatic proliferative vitreoretinopathy"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-2058","authenticated-orcid":false,"given":"Mengyu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2519-8371","authenticated-orcid":false,"given":"Yumei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5133-5146","authenticated-orcid":false,"given":"Xiaoping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4365-5535","authenticated-orcid":false,"given":"Youhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1140-8419","authenticated-orcid":false,"given":"Yumeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0130-7738","authenticated-orcid":false,"given":"Zhisheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1258-8232","authenticated-orcid":false,"given":"Xu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-6996","authenticated-orcid":false,"given":"Minghui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9890-6208","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-5666","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-243X","authenticated-orcid":false,"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-0079","authenticated-orcid":false,"given":"Ziming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-9547","authenticated-orcid":false,"given":"Yupeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7651-840X","authenticated-orcid":false,"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,25]]},"reference":[{"key":"51624_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1442-9071.2009.01922.x","volume":"36","author":"B Knyazer","year":"2008","unstructured":"Knyazer, B. et al. Prognostic factors in posterior open globe injuries (zone-III injuries). Clin. Exp. Ophthalmol. 36, 836\u2013841 (2008).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"51624_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.ophtha.2008.05.013","volume":"115","author":"MH Colyer","year":"2008","unstructured":"Colyer, M. H., Chun, D. W., Bower, K. S., Dick, J. S. & Weichel, E. D. Perforating globe injuries during operation Iraqi Freedom. Ophthalmology 115, 2087\u20132093 (2008).","journal-title":"Ophthalmology"},{"key":"51624_CR3","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1097\/IAE.0000000000001350","volume":"37","author":"Y Jin","year":"2017","unstructured":"Jin, Y. et al. TRAUMATIC PROLIFERATIVE VITREORETINOPATHY: Clinical and Histopathological Observations. Retina 37, 1236\u20131245 (2017).","journal-title":"Retina"},{"key":"51624_CR4","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0161-6420(97)30167-5","volume":"104","author":"JA Cardillo","year":"1997","unstructured":"Cardillo, J. A. et al. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104, 1166\u20131173 (1997).","journal-title":"Ophthalmology"},{"key":"51624_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.preteyeres.2013.12.006","volume":"40","author":"S Pennock","year":"2014","unstructured":"Pennock, S., Haddock, L. J., Eliott, D., Mukai, S. & Kazlauskas, A. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog. Retin Eye Res. 40, 16\u201334 (2014).","journal-title":"Prog. Retin Eye Res."},{"key":"51624_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","volume":"51","author":"JC Pastor","year":"2016","unstructured":"Pastor, J. C. et al. Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences. Prog. Retin Eye Res. 51, 125\u2013155 (2016).","journal-title":"Prog. Retin Eye Res."},{"key":"51624_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/atm.2020.03.86","volume":"8","author":"X Li","year":"2020","unstructured":"Li, X., Zhao, M. & He, S. RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy. Ann. Transl. Med. 8, 263 (2020).","journal-title":"Ann. Transl. Med."},{"key":"51624_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1350-9462(01)00023-4","volume":"21","author":"JC Pastor","year":"2002","unstructured":"Pastor, J. C., de la R\u00faa, E. R. & Mart\u00edn, F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog. Retin Eye Res. 21, 127\u2013144 (2002).","journal-title":"Prog. Retin Eye Res."},{"key":"51624_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2015.02.008","volume":"142","author":"S Tamiya","year":"2016","unstructured":"Tamiya, S. & Kaplan, H. J. Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Exp. Eye Res 142, 26\u201331 (2016).","journal-title":"Exp. Eye Res"},{"key":"51624_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/269787","volume":"2013","author":"F Morescalchi","year":"2013","unstructured":"Morescalchi, F. et al. Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid. Mediators Inflamm. 2013, 269787 (2013).","journal-title":"Mediators Inflamm."},{"key":"51624_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.devcel.2016.08.004","volume":"38","author":"M Perino","year":"2016","unstructured":"Perino, M. & Veenstra, G. J. Chromatin Control of Developmental Dynamics and Plasticity. Dev. Cell 38, 610\u2013620 (2016).","journal-title":"Dev. Cell"},{"key":"51624_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91\u2013100 (2012).","journal-title":"Nature"},{"key":"51624_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrg3623","volume":"15","author":"TC Voss","year":"2014","unstructured":"Voss, T. C. & Hager, G. L. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat. Rev. Genet. 15, 69\u201381 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"51624_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41568-020-0288-4","volume":"20","author":"BA Nacev","year":"2020","unstructured":"Nacev, B. A. et al. The epigenomics of sarcoma. Nat. Rev. Cancer 20, 608\u2013623 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"51624_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41576-021-00348-6","volume":"22","author":"ES Oh","year":"2021","unstructured":"Oh, E. S. & Petronis, A. Origins of human disease: the chrono-epigenetic perspective. Nat. Rev. Genet. 22, 533\u2013546 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"51624_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1006\/exer.2002.2031","volume":"75","author":"MV Cant\u00f3 Soler","year":"2002","unstructured":"Cant\u00f3 Soler, M. V., Gallo, J. E., Dodds, R. A. & Suburo, A. M. A mouse model of proliferative vitreoretinopathy induced by dispase. Exp. Eye Res. 75, 491\u2013504 (2002).","journal-title":"Exp. Eye Res."},{"key":"51624_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuropharm.2016.08.030","volume":"113","author":"AM Szczesniak","year":"2017","unstructured":"Szczesniak, A. M. et al. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Neuropharmacology 113, 627\u2013638 (2017).","journal-title":"Neuropharmacology"},{"key":"51624_CR18","first-page":"933","volume":"23","author":"K Yoo","year":"2017","unstructured":"Yoo, K. et al. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-\u03b1. Mol. Vis. 23, 933\u2013943 (2017).","journal-title":"Mol. Vis."},{"key":"51624_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2353\/ajpath.2008.070605","volume":"172","author":"M Iribarne","year":"2008","unstructured":"Iribarne, M. et al. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. Am. J. Pathol. 172, 1030\u20131042 (2008).","journal-title":"Am. J. Pathol."},{"key":"51624_CR20","doi-asserted-by":"publisher","first-page":"jcs238279","DOI":"10.1242\/jcs.238279","volume":"133","author":"T Storm","year":"2020","unstructured":"Storm, T., Burgoyne, T. & Futter, C. E. Membrane trafficking in the retinal pigment epithelium at a glance. J. Cell Sci. 133, jcs238279 (2020).","journal-title":"J. Cell Sci."},{"key":"51624_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fcell.2020.00501","volume":"8","author":"M Zhou","year":"2020","unstructured":"Zhou, M. et al. Role of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Dysfunction. Front. Cell Dev. Biol. 8, 501 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"51624_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/s41374-019-0307-9","volume":"99","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells. Lab. Invest. 99, 1874\u20131886 (2019).","journal-title":"Lab. Invest."},{"key":"51624_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"51624_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13238-020-00757-z","volume":"12","author":"R Xu","year":"2021","unstructured":"Xu, R., Li, C., Liu, X. & Gao, S. Insights into epigenetic patterns in mammalian early embryos. Protein Cell 12, 7\u201328 (2021).","journal-title":"Protein Cell"},{"key":"51624_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77254-0","volume":"10","author":"S Delgado-Tirado","year":"2020","unstructured":"Delgado-Tirado, S. et al. Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy. Sci. Rep. 10, 20554 (2020).","journal-title":"Sci. Rep."},{"key":"51624_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.5.17","volume":"63","author":"Y Laich","year":"2022","unstructured":"Laich, Y. et al. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 63, 17 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51624_CR27","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3390\/antiox11102080","volume":"11","author":"I Wada","year":"2022","unstructured":"Wada, I. et al. Mechanisms of Epithelial-Mesenchymal Transition and Prevention of Dispase-Induced PVR by Delivery of an Antioxidant \u03b1B Crystallin Peptide. Antioxid. (Basel) 11, 2080 (2022).","journal-title":"Antioxid. (Basel)"},{"key":"51624_CR28","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood-2017-09-808063","volume":"131","author":"Y Jin","year":"2018","unstructured":"Jin, Y. et al. Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma. Blood 131, 2138\u20132150 (2018).","journal-title":"Blood"},{"key":"51624_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab. 35, 943\u2013960.e949 (2023).","journal-title":"Cell Metab."},{"key":"51624_CR30","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.celrep.2018.10.003","volume":"25","author":"T Wu","year":"2018","unstructured":"Wu, T., Kamikawa, Y. F. & Donohoe, M. E. Brd4\u2019s Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1. Cell Rep. 25, 1756\u20131771 (2018).","journal-title":"Cell Rep."},{"key":"51624_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","volume":"19","author":"MK Jang","year":"2005","unstructured":"Jang, M. K. et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19, 523\u2013534 (2005).","journal-title":"Mol. Cell"},{"key":"51624_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang, Z. et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19, 535\u2013545 (2005).","journal-title":"Mol. Cell"},{"key":"51624_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrm.2016.143","volume":"18","author":"T Fujisawa","year":"2017","unstructured":"Fujisawa, T. & Filippakopoulos, P. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nat. Rev. Mol. Cell Biol. 18, 246\u2013262 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"51624_CR34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"51624_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.celrep.2016.03.054","volume":"15","author":"AS Bhagwat","year":"2016","unstructured":"Bhagwat, A. S. et al. BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements. Cell Rep. 15, 519\u2013530 (2016).","journal-title":"Cell Rep."},{"key":"51624_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.gendis.2020.12.012","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. BET bromodomain inhibitor JQ1 regulates spermatid development by changing chromatin conformation in mouse spermatogenesis. Genes Dis. 9, 1062\u20131073 (2022).","journal-title":"Genes Dis."},{"key":"51624_CR37","doi-asserted-by":"publisher","DOI":"10.5702\/massspectrometry.A0110","volume":"11","author":"N Azegami","year":"2022","unstructured":"Azegami, N. et al. Native Mass Spectrometry of BRD4 Bromodomains Linked to a Long Disordered Region. Mass Spectrom 11, A0110 (2022).","journal-title":"Mass Spectrom"},{"key":"51624_CR38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1096\/fj.13-235440","volume":"28","author":"J Galvao","year":"2014","unstructured":"Galvao, J. et al. Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J. 28, 1317\u20131330 (2014).","journal-title":"FASEB J."},{"key":"51624_CR39","doi-asserted-by":"publisher","first-page":"114582","DOI":"10.1016\/j.addr.2022.114582","volume":"191","author":"N Nagai","year":"2022","unstructured":"Nagai, N. & Otake, H. Novel drug delivery systems for the management of dry eye. Adv. Drug Deliv. Rev. 191, 114582 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"51624_CR40","doi-asserted-by":"publisher","first-page":"119313","DOI":"10.1016\/j.ijpharm.2020.119313","volume":"582","author":"MA El-Gendy","year":"2020","unstructured":"El-Gendy, M. A., Mansour, M., El-Assal, M. I. A., Ishak, R. A. H. & Mortada, N. D. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery. Int. J. Pharm. 582, 119313 (2020).","journal-title":"Int. J. Pharm."},{"key":"51624_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/gels8070412","volume":"8","author":"A Nawaz","year":"2022","unstructured":"Nawaz, A. et al. Synthesis and Characterization of Chitosan-Decorated Nanoemulsion Gel of 5-Fluorouracil for Topical Delivery. Gels 8, 412 (2022).","journal-title":"Gels"},{"key":"51624_CR42","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1080\/09205063.2022.2088527","volume":"33","author":"N Vasdev","year":"2022","unstructured":"Vasdev, N., Handa, M., Kesharwani, P. & Shukla, R. Rosemary oil low energy nanoemulsion: optimization, \u00b5rheology, in silico, in vitro, and ex vivo characterization. J. Biomater. Sci. Polym. Ed. 33, 1901\u20131923 (2022).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"51624_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cels.2017.07.004","volume":"5","author":"AC Wilkinson","year":"2017","unstructured":"Wilkinson, A. C., Nakauchi, H. & G\u00f6ttgens, B. Mammalian Transcription Factor Networks: Recent Advances in Interrogating Biological Complexity. Cell Syst. 5, 319\u2013331 (2017).","journal-title":"Cell Syst."},{"key":"51624_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108859","volume":"213","author":"ZY Wang","year":"2021","unstructured":"Wang, Z. Y. et al. Artesunate inhibits the development of PVR by suppressing the TGF-\u03b2\/Smad signaling pathway. Exp. Eye Res. 213, 108859 (2021).","journal-title":"Exp. Eye Res."},{"key":"51624_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/labinvest.3700156","volume":"84","author":"S Saika","year":"2004","unstructured":"Saika, S. et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab. Invest. 84, 1245\u20131258 (2004).","journal-title":"Lab. Invest."},{"key":"51624_CR46","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"51624_CR47","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261\u20131269 (2005).","journal-title":"J. Exp. Med."},{"key":"51624_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.preteyeres.2012.09.001","volume":"32","author":"DM Lipinski","year":"2013","unstructured":"Lipinski, D. M., Thake, M. & MacLaren, R. E. Clinical applications of retinal gene therapy. Prog. Retin Eye Res. 32, 22\u201347 (2013).","journal-title":"Prog. Retin Eye Res."},{"key":"51624_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"51624_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175\u2013179 (1997).","journal-title":"Nature"},{"key":"51624_CR51","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 19, 626\u2013642 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"51624_CR52","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc. Natl Acad. Sci. USA 95, 3597\u20133602 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51624_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165\u2013176 (1998).","journal-title":"Cell"},{"key":"51624_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey, D. L. et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat. Rev. Drug Discov. 11, 401\u2013419 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"51624_CR55","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10136","volume":"8","author":"H Zou","year":"2020","unstructured":"Zou, H. et al. Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. PeerJ 8, e10136 (2020).","journal-title":"PeerJ"},{"key":"51624_CR56","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1167\/iovs.14-16258","volume":"56","author":"S He","year":"2015","unstructured":"He, S. et al. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 56, 5579\u20135589 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51624_CR57","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.stemcr.2020.03.009","volume":"14","author":"NC Boles","year":"2020","unstructured":"Boles, N. C. et al. Epigenomic and Transcriptomic Changes During Human RPE EMT in a Stem Cell Model of Epiretinal Membrane Pathogenesis and Prevention by Nicotinamide. Stem Cell Rep. 14, 631\u2013647 (2020).","journal-title":"Stem Cell Rep."},{"key":"51624_CR58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/jcmm.12212","volume":"18","author":"W Xiao","year":"2014","unstructured":"Xiao, W. et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. J. Cell Mol. Med. 18, 646\u2013655 (2014).","journal-title":"J. Cell Mol. Med."},{"key":"51624_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2021.01.060","volume":"544","author":"H Hatanaka","year":"2021","unstructured":"Hatanaka, H. et al. Epigenetic regulation of the epithelial mesenchymal transition induced by synergistic action of TNF-\u03b1 and TGF-\u03b2 in retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 544, 31\u201337 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"51624_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/IAE.0000000000000447","volume":"35","author":"MA Khan","year":"2015","unstructured":"Khan, M. A., Brady, C. J. & Kaiser, R. S. Clinical management of proliferative vitreoretinopathy: an update. Retina 35, 165\u2013175 (2015).","journal-title":"Retina"},{"key":"51624_CR61","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"PJ Bekker","year":"2004","unstructured":"Bekker, P. J. et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J. Bone Min. Res. 19, 1059\u20131066 (2004).","journal-title":"J. Bone Min. Res."},{"key":"51624_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik, P. J. et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J. Bone Min. Res. 24, 182\u2013195 (2009).","journal-title":"J. Bone Min. Res."},{"key":"51624_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.62.9.29","volume":"62","author":"H Han","year":"2021","unstructured":"Han, H. et al. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition. Invest. Ophthalmol. Vis. Sci. 62, 29 (2021).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51624_CR64","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/nprot.2016.065","volume":"11","author":"R Fernandez-Godino","year":"2016","unstructured":"Fernandez-Godino, R., Garland, D. L. & Pierce, E. A. Isolation, culture and characterization of primary mouse RPE cells. Nat. Protoc. 11, 1206\u20131218 (2016).","journal-title":"Nat. Protoc."},{"key":"51624_CR65","doi-asserted-by":"crossref","unstructured":"Shang, P. et al. Primary Cell Cultures from the Mouse Retinal Pigment Epithelium. J. Vis. Exp. 133, 56997 (2018).","DOI":"10.3791\/56997-v"},{"key":"51624_CR66","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature19361","volume":"537","author":"B Zhang","year":"2016","unstructured":"Zhang, B. et al. Allelic reprogramming of the histone modification H3K4me3 in early mammalian development. Nature 537, 553\u2013557 (2016).","journal-title":"Nature"},{"key":"51624_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan, J. & Kantharia, N. D. How to calculate sample size in animal studies? J. Pharm. Pharmacother. 4, 303\u2013306 (2013).","journal-title":"J. Pharm. Pharmacother."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51624-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T10:02:24Z","timestamp":1724580144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51624"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51624-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,25]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A patent application (P.R.C application number: 202410504090.1) was filed by Tianjin Medical University General Hospital. H.Y., Y.C., M.L., Y.L., Y.Z., and Z.Y. from Tianjin Medical University, Z.Z. and Y.H. from Xuzhou Medical University are inventors. The patent application covered the preparation methods for eNano-JQ1 and their intraocular application. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7324"}}